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Abstract
Background: The assembly of nucleosomes to higher-order chromatin structures is finely tuned
by the relative affinities of histones for chaperones and nucleosomal binding sites. The myeloid
leukaemia protein SET/TAF-Iβ belongs to the NAP1 family of histone chaperones and participates
in several chromatin-based mechanisms, such as chromatin assembly, nucleosome reorganisation
and transcriptional activation. To better understand the histone chaperone function of SET/TAF-
Iβ, we designed several SET/TAF-Iβ truncations, examined their structural integrity by circular
Dichroism and assessed qualitatively and quantitatively the histone binding properties of wild-type
protein and mutant forms using GST-pull down experiments and fluorescence spectroscopy-based
binding assays.
Results: Wild type SET/TAF-Iβ binds to histones H2B and H3 with Kd values of 2.87 and 0.15 μM,
respectively. The preferential binding of SET/TAF-Iβ to histone H3 is mediated by its central region
and the globular part of H3. On the contrary, the acidic C-terminal tail and the amino-terminal
dimerisation domain of SET/TAF-Iβ, as well as the H3 amino-terminal tail, are dispensable for this
interaction.
Conclusion: This type of analysis allowed us to assess the relative affinities of SET/TAF-Iβ for
different histones and identify the domains of the protein required for effective histone recognition.
Our findings are consistent with recent structural studies of SET/TAF-Iβ and can be valuable to
understand the role of SET/TAF-Iβ in chromatin function.
Background
The genomes of eukaryotic cells are organized as chroma-
tin, a highly dynamic complex between DNA and his-
tones. The fundamental repeating unit in chromatin is the
nucleosome core particle (NCP), which is composed of
147 bp of DNA wrapped around an octameric core con-
taining two copies of each of the four histones H2A, H2B,
H3, and H4 [1]. Ultimately, long arrays of nucleosomes
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are further compacted into higher-order structures that
form functional chromatin domains. The packaging of
DNA into chromatin ensures genome stability, but at the
same time creates a barrier for the access of cellular factors
to underlying DNA sequences, thus influencing gene
expression, DNA replication, recombination and repair
[2]. The major mechanisms which modulate chromatin
structure include ATP-dependent nucleosome remodeling
complexes, covalent modification of histones, histone
variant exchange and histone chaperones [3]. ATP-
dependent remodeling complexes use the energy of ATP
hydrolysis to regulate chromatin fluidity, leading to either
activation or repression of transcription [4,5]. Recent
studies have revealed a large number of post-translational
modifications that lie either in the flexible histone tails or
in the histone globular domain, which are correlated with
distinct functional states of chromatin [6-8]. In concert to
these machineries, non-histone proteins and histone
chaperones regulate nucleosome dynamics by influencing
the binding affinity of histones for DNA [9].
Histone chaperones are key players in the organisation of
chromatin domains [9-11]. They shield the positive
charge of histones and safeguard them from improper
electrostatic interactions with DNA or other proteins
which could be harmful for the cell. Consequently, they
mediate chromatin assembly/disassembly, histone stor-
age and coordinate the exchange/deposition of histones
onto DNA during replication. The best characterised chap-
erones are NAP1 [12,13], chromatin assembly factor 1
(CAF1) [14], N1/N2 [15], nucleoplasmin [16], anti-
silencing factor (ASF1) [17] and HIRA [18]. Despite the
fact that all chaperones bind to histones, they seem to
mediate distinct protein-protein interactions in vivo and
their histone partners and binding affinities vary consid-
erably.
The myeloid leukaemia protein SET/TAF-1β studied here,
also known as I2PP2A, and INHAT, belongs to the NAP1
family of histone chaperones. It was originally identified
as a translocated gene in acute undifferentiated leukemia
[19-21] and is widely expressed in human and mouse tis-
sues [22]. The analysis of SET/TAF-Iβ functions is chal-
lenging, because it is involved in a broad range of cellular
mechanisms and it remains unclear how it switches
between these different functions. SET/TAF-Iβ is a potent
inhibitor of phosphatase 2A (PP2A), and interacts with
several proteins involved in the regulation of cell cycle,
such as p21waf1 [23], cyclin E-CDK2 [23], B- cyclins [24]
and p35nck5a [25]. Furthermore, SET/TAF-Iβ has been
identified as a key factor of the cytotoxic T lymphocytes
(CTL)-induced cell death, suggesting its role in the regula-
tion of apoptosis [26]. Besides its involvement in the con-
trol of cell cycle and apoptosis, increasing number of
reports describe the chromatin-related properties of SET/
TAF-Iβ. It stimulates DNA replication and transcription of
the adenovirus genome [27-30] and induces chromatin
decondensation [31]. Other studies have shown that SET/
TAF-Iβ binds to nucleosomal histones [32-34] and inhib-
its histone acetylation by masking histone tails as a com-
ponent of the INHAT complex [35]. In addition, we have
previously reported the interaction of SET/TAF-Iβ with the
chromatin remodeling protein prothymosin α [36] and
the transcription coactivator CREB-binding protein (CBP)
[37]. Consistent with the above studies, a DNA-microar-
ray based analysis revealed that SET/TAF-Iβ stimulates the
transcription of a sub-set of genes [38]. Interestingly, the
transcription of the endogenous genes which were upreg-
ulated by SET/TAF-Iβ was found to be additively stimu-
lated by histone acetylation. Recently, Ichijo et al [39]
showed that Set/TAF-Iβ interacts with the activated gluco-
corticoid receptor and acts as a ligand-activated GR-
responsive transcriptional repressor, which further sug-
gests the involvement of this protein in transcriptional
regulation.
Inspection of the aminoacid sequence of SET/TAF-Iβ
reveals three interesting structural features, which are
important determinants of its ligand binding activity and,
ultimately, of its functional specificity. First, a motif
located in the N-terminal region (amino acids 1–76) pre-
dicted to form a coiled-coil structure, which is believed to
mediate the dimerisation of the protein [40]. Dimerisa-
tion is a conserved feature of the NAP1 family of histone
chaperones and it was found to be necessary for the chro-
matin remodeling activity of SET/TAF-Iβ [40]. Second, the
central NAP domain (amino acids 80–225), which is
highly conserved among the NAP1 protein family mem-
bers and is thought to mediate histone fold-specific bind-
ing [12,13]. Third, a highly acidic polyglutamic track
located in the C-terminal tail of SET/TAF-Iβ (amino acids
226–277). This region consists of 42 glutamic and aspar-
tic residues occasionally interspersed by glycine residues
and seems to adopt an intrinsically disordered structure
that provides structural plasticity, according to recent CD
and X-Ray data on yeast NAP1 [12,41]. In vitro experi-
ments suggested that the acidic tail might be implicated in
the chaperone activity of SET/TAF-Iβ, targeting the basic
N-terminal tails of histones [31,42]. However, it is still
unclear which domains of the protein are required for
effective histone recognition. In addition, the relative
affinity of SET/TAF-Iβ for the various histones remains
unknown. This information can be very valuable to
understand the role of SET/TAF-Iβ as a histone chaperone,
since histone binding activity is the common feature of
this class of proteins, through which they are involved in
a wide range of mechanisms, besides nucleosome assem-
bly/disassembly, such as histone variant exchange, his-
tone modification regulation, histone shuttling and
storage and transient histone overload buffering [43,44].BMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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Moreover, it has been recently shown that the assembly of
nucleosomes to the level of chromatin is governed by
affinity differences of histones between chaperones and
binding sites on subnucleosomal complexes [41,45].
Here, we focused on the histone-binding properties of
SET/TAF-Iβ. We performed GST-pull down analysis with
wild type SET/TAF-Iβ and all five histones and fluores-
cence spectroscopy-based quantitative binding assays
with those histones that appeared to interact with SET/
TAF-Iβ. This analysis allowed us to assess the relative affin-
ity of SET/TAF-Iβ for different histones. Such detailed
analysis has not, to our knowledge, been carried out for
this protein. Furthermore, in order to identify the regions
of the protein responsible for the interaction with his-
tones, we designed several SET/TAF-Iβ truncations, exam-
ined their structural integrity by circular dichroism and
assessed qualitatively and quantitatively their histone-
binding properties by GST-pull down assays and fluores-
cence spectroscopy-based titration experiments. Collec-
tively, our data show that SET/TAF-Iβ binds preferentially
to histone H3 through its central region. The dimerisation
domain of SET/TAF-Iβ, as well as its C-terminal acidic tail,
are not essential for this interaction.
Results
Preferential binding of of SET/TAF-Iβ to histone H3
To study the histone binding activity of SET/TAF-Iβ, we
performed GST-pull down assays. GST-SET/TAF-Iβ was
immobilised on glutathione beads and challenged with
H1 or core histones at high salt concentrations. The results
revealed binding of SET/TAF-Iβ to histones H2B (Fig. 1A,
lane 6) and H3 (lane 8), while no interaction was
observed with histones H1 (lane 2), H2A (lane 4) and H4
(lane 10). GST immobilized on glutathione beads was
used as a negative control (not shown).
To compare quantitatively the relative affinity of SET/TAF-
Iβ for histones H3 and H2B, we performed fluorescence-
based titration experiments [46,47]. SET/TAF-Iβ sequence
contains four tryptophan residues, which could serve as
intrinsic fluorescence chromophores. On the other hand,
histones are poor in aromatic amino acids and completely
devoid of tryptophan residues. Therefore, the binding
affinity of SET/TAF-Iβ to histones H3 and H2B could be
monitored by fluorescence spectroscopy at an excitation
wavelength that precludes a contribution to the emitted
fluorescence intensity from the tyrosine residues of his-
tones. A clear and gradual quenching of the fluorescence
signal was observed, when increasing amounts of histones
were added to full-length SET/TAF-Iβ. The fluorescence
intensity change was used for a quantitative binding assay.
A binding curve was obtained by monitoring the intensity
at 345 nm of the fluorescence emitted by SET/TAF-Iβ as a
function of added histone concentration at constant tem-
perature (Fig. 1B). Fitting of the fluorescence data resulted
in a Kd value of 0.15 μM for the SET/TAF-Iβ-H3 interaction
and a Kd value of 2.87 μM for the SET/TAF-Iβ-H2B interac-
tion (Table 1). The qualitative and quantitative assess-
ment of the SET/TAF-Iβ-histone interaction points to a
clear preference of SET/TAF-1β for histone H3. Pull-down
experiments with GST-fused SET/TAF-Iβ and reconstituted
(H3/H4)2 tetramers showed that this interaction is also
efficient in the more "organized" context of the (H3/H4)2
tetramer (Fig. 1C). In this sense, SET/TAF-Iβ behaves sim-
ilarly to NAP1 from yeast, Drosophila and humans which
have been shown to preferentially bind the (H3/H4)2
tetramer in vitro [41], although NAP family members have
generally been described as H2A/H2B chaperones. On the
contrary, yeast NAP1 is capable of binding to linker his-
tone H1 [48], while our data rule out such a possibility for
SET/TAF-Iβ (Fig. 1A, lane 2). NAP1 from yeast and
humans has also been shown to facilitate the removal of
H2A-H2B dimers from a folded nucleosome [49,50], but
in the same set of experiments, SET/TAF-Iβ did not dem-
onstrate an efficient stripping activity of the dimer [49].
This difference together with the clear preference of SET/
TAF-Iβ for H3 binding and with the lack of interaction
with linker histone H1 may account, at least in part, for
distinct roles of SET/TAF-Iβ in diverse mechanisms of
nucleosome assembly and reorganization.
Individual domains of SET/TAF-Iβ are sufficient for 
histonebinding
Since H3 was identified as the preferred histone substrate
of SET/TAF-Iβ, we proceeded to identify the regions of
SET/TAF-Iβ involved in H3 binding. Based on sequence
comparisons between human SET/TAF-Iβ and members
of the Nucleosome Assembly Protein (NAP) family, in
particular NAP-1 from yeast, whose three-dimensional
structure was recently solved [12] (PDB ID: 2AYU), we
designed several deletion mutants of SET/TAF-Iβ, shown
in Fig. 2A. Our specific aim in the design of the mutants
was to challenge the role in H3 binding of (i) the dimeri-
sation domain, (ii) the acidic C-terminal tail and (iii) the
central region of the protein. Previous structural and bio-
chemical studies have underlined the essential role of the
central region of NAP1 proteins in the interaction with
histones; the β-sheet subdomain, which is part of this
region, is structurally conserved in otherwise unrelated in
sequence and structure histone chaperones and is
believed to form a scaffold onto which histone binding
elements are built [12].
Wild type SET/TAF-Iβ and its mutants were expressed and
purified as GST-tagged proteins and subsequently the GST
moeity was removed, as indicated in the Methods section
(Fig. 2B). The structural integrity of wild-type and mutant
forms of SET/TAF-Iβ was explored by Circular Dichroism
Spectroscopy (CD). All constructs tested, with the excep-
tion of the polypeptide spanning residues 110–210 of
the protein, were found well folded (Fig. 2C). The CDBMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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Histone binding properties of SET/TAF-Iβ Figure 1
Histone binding properties of SET/TAF-Iβ. (A) SET/TAF-Iβ binding to histones. Purified GST-SET/TAF-Iβ (2 μg) was immo-
bilised on glutathione-agarose beads and incubated with 4 μg of H1 (lane 2) or core histones H2A, H2B, H3, H4 (lanes 4, 6, 8, 
10, respectively) as indicated in Materials and Methods. The beads were washed and analysed by SDS-PAGE and Coomassie 
blue staining. Lanes 1, 3, 5, 7, 9 indicate the input of the histones. (B) Fluorescence-based binding assays. SET/TAF-Iβ at an initial 
concentration of 4 μM was titrated with increasing amounts of purified calf thymus H3 (left panel) or H2B (right panel) stock 
solutions in PBS buffer. SET/TAF-Iβ binding to histones H3 and H2B was followed by monitoring the intensity of the fluores-
cence emitted at 345 nm after excitation at 295 nm. The solid line represents the binding curve derived by non-linear regres-
sion analysis of the fluorescence values corrected for dilution and for buffer contribution. (C) SET/TAF-Iβ binding to (H3/H4)2 
tetramers. GST (lane 1) and GST-SET/TAF-Iβ (lane 2) were immobilised on glutathione-agarose beads and incubated with 
reconstituted (H3/H4)2 tetramers (lane 3) as indicated in Materials and Methods. The beads were washed and bound proteins 
were analysed by SDS-PAGE and Coomassie blue staining.BMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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spectrum of full-length SET/TAF-Iβ is indicative of a pre-
dominantly α-helical protein. The proportion of the two
main types of secondary structure varies significantly
between the different mutants, depending on whether the
N-terminal  α-helical part or the C-terminal disordered
region is included in each construct. It should be noted at
this point that the C-terminal acidic stretch, the only part
of the protein expected to be completely disordered in
solution, was not analysed by CD due to technical prob-
lems during its purification.
In order to test the binding activity of SET/TAF-Iβ frag-
ments for histone H3, we first carried out series of GST-
pull down experiments with all GST-tagged mutants and
H3. As shown in Figure 3A, all SET/TAF-Iβ fragments had
the ability to interact with H3, with the exception of the
polypeptide SET/TAF-Iβ 110–210, which was found mis-
folded and aggregated. These results suggest that the bind-
ing site of SET/TAF-Iβ for H3 resides mainly within its
central region, despite the fact that the protein possesses a
C-terminal region of pronounced negative charge. Moreo-
ver, it appears that dimerisation of SET/TAF-Iβ is not
essential for the interaction, since mutants lacking the
complete N-terminal dimerisation domain (residues 1–
76) do not fail to bind H3 (Fig. 3A, lanes 6, 9, 10).
To assess the relative affinities of the isolated SET/TAF-Iβ
deletion mutants for H3 (Fig. 2B), we resorted again to
fluorescence-based titration experiments. All SET/TAF-Iβ
mutants have one or more tryptophan residues in their
sequence which could function as intrinsic fluorescence
chromophores. The results are consistent with the pull
down assays, supporting further the importance of the
central region of SET in its interaction with H3. They show
that, in general, shorter constructs centered around the
central region of SET/TAF-Iβ (amino acids 76–185) and
lacking either the N-terminal dimerisation domain and/
or the acidic C-terminal tail are sufficient for H3 binding
and their affinities for H3 are comparable to that of the
full length protein (summarized in Table 1). The homol-
ogous region of yeast NAP1 has been shown to be crucial
for the interaction with histones and has been termed
"protein interaction domain" [12]. Besides the length of
the mutants able to bind H3, the values of Kd's of most
complexes and the stoichiometry deduced from the bind-
ing curves, clearly indicate that neither dimerisation nor
the acidic tail-domain of SET/TAF-Iβ are absolutely neces-
sary for the interaction (for example, compare the Kd's of
the complexes H3-SET/TAF-Iβ (1–277) and H3-SET/TAF-
Iβ (76–210) (Table 1). Our data are in agreement with
previous observations on the 1:1 stoichiometry for yeast
NAP1/H3 interaction [41].
We next attempted to identify the region of histone H3,
which is involved in its binding with SET/TAF-Iβ. To this
end, GST-fused recombinant H3 tail was tested for its abil-
itity to bind wild type and SET/TAF-Iβ (76–185) in pull
down assays. Figure 3B shows that no binding to the
amino terminal tail of H3 was detected. In contrast, bind-
ing of both proteins to the globular domain of H3 was
observed (Fig. 3C, lanes 1, 2). These results suggest that
the H3 N-terminal tail is not required for its interaction
with SET/TAF-Iβ. On the contrary, they indicate that bind-
ing determinants of the SET/TAF-Iβ/H3 interaction lie
within the globular domain of H3. This finding contra-
dicts a previous study showing direct binding of SET/TAF-
Iβ to the H3 N-terminal tail, which is disrupted when the
tail is modified [34]. Discrepancies between the two stud-
ies might result from differences in the assays and the H3
fragments used. We tested full-length, native histone H3
with wild type SET/TAF-Iβ and its deletion mutants in our
binding assays (Figs. 1A, 1B, 3A). We also used recom-
binant forms of full length H3 (Fig. 3C, lanes 4, 5), the
globular part of H3 and its N-terminal tail (H3 residues 1–
46). On the contrary, in the above study, SET/TAF-Iβ bind-
ing to H3 was tested using short synthetic peptides corre-
sponding to residues 1–16 of H3, immobilized on
columns [34]. Our data clearly show that the binding of
SET/TAF-Iβ to H3 occurs with native H3 (Figs. 1A, 1B, 3A),
which is heavily modified (S. Liokatis and A.S. Politou,
unpublished results) and with recombinant forms of
intact H3 and of its core region (Fig. 3C), which are
devoid of any post-translational modifications. On the
other hand, the binding is abolished when unmodified
H3 tail is used in the pull-down assays (Fig. 3B). There-
fore, neither the amino-terminal tail nor any modifica-
tions (either in the core or in the tail) of H3 seem to play
an essential role in its interaction with SET/TAF-Iβ.
Discussion
The histone binding studies described in this work were
made with wild-type and SET/TAF-Iβ deletion mutants.
These mutants were designed on the basis of its sequence
similarity to NAP-1 from yeast, whose three-dimensional
Table 1: Relative affinities of SET-TAFI-β and its deletion 
mutants for H3
SET/TAF-Iβ construct Kd Pull-down results
SET 1–277 0.15 ± 0.20 +
SET 1–210 0.13 ± 0.10 +
SET 76–210 0.14 ± 0.08 +
SET 76–185 0.10 ± 0.08 +
SET 110–277 0.16 ± 0.12 +
SET 110–210 n.d. -
Binding of the various SET/TAF-Iβ deletion mutants with histone H3 
was followed by monitoring the intensity of the fluorescence emitted 
by the tryptophan residues of SET/TAF-Iβ polypeptides upon addition 
of increasing amounts of calf thymus histone H3. The dissociation 
constant (Kd) for the complexes formed was estimated by non-linear 
regression analysis (KaleidaGraph, Synergy Software), as indicated in 
Methods.BMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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Design and structural integrity of SET/TAF-Iβ deletion constructs Figure 2
Design and structural integrity of SET/TAF-Iβ deletion constructs. (A) Aminoacid sequence and secondary structure 
elements of SET/TAF-1β (PBD code 2E250) and its deletion mutants; SET/TAF-Iβ (1–210) (yellow), SET/TAF-Iβ (76–210) (red), 
SET/TAF-Iβ (76–185) (blue), SET/TAF-Iβ (110–277) (orange), SET/TAF-Iβ (110–210) (green)(insert). Residues in the acidic 
stretch are shown in grey. (B) Wild type SET/TAF-Iβ and its deletion mutants were expressed and purified as GST-tagged pro-
teins and subsequently the GST moiety was removed, as indicated in the Methods section. The proteins were analysed by SDS-
PAGE and Coomassie blue staining. (C) Circular dichroism spectra of wild type SET/TAF-Iβ (1–277) (filled hexagon), SET/TAF-
Iβ (1–210) (filled diamond), SET/TAF-Iβ 110–277 (open hexagon), SET/TAF-Iβ 76–185 (open diamond) and SET/TAF-Iβ (76–
210) (open square). Stock solutions of SET/TAF-IB polypeptides were in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM DTT, 
1 mM EDTA in a concentration range of 10–75 μM.BMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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structure was known [12], since the structure of SET/TAF-
Iβ had not been determined yet. While this manuscript
was in preparation, the crystal structure of SET/TAF-Iβ was
reported (PDB ID: 2E50) [51]. The crystal structure shows
that SET/TAF-Iβ forms a dimer that assumes a headphone
like shape, with each subunit consisting only of an unsta-
ble and highly mobile α-helix, a long backbone helix, and
an α+β "earmuff domain" (amino acids 1–24, 25–78, and
79–225, respectively). The two backbone helices are not
arranged in a coiled-coil fashion, but interact hydropho-
Binding of SET/TAF-Iβ proteins to histone H3 Figure 3
Binding of SET/TAF-Iβ proteins to histone H3. (A) GST-SET/TAF-Iβ (lane 3), GST-SET/TAF-Iβ constructs (lanes 4, 5, 6, 
9, 10) and purified GST (lanes 2, 8) (4 μg each) were immobilised on glutathione-agarose beads and incubated with 4 μg of his-
tone H3. The beads were washed and analysed by SDS-PAGE and Coomassie blue staining. Lanes 1 and 7 indicate the input of 
histone H3. (B) GST-H3 tail (lanes 1,2) or GST (lanes 3, 4) (2 μg each) were bound on glutathione-agarose beads and incubated 
with 4 μg of SET/TAFI-β (76–185) (lanes 1, 3) or wild type SET/TAFI-β (lanes 2, 4). The beads were washed and analysed by 
SDS-PAGE and Coomassie blue staining. The input of SET/TAFI-β and SET/TAFI-β (76–185) is shown in lanes 5, 6. (C)GST 
(lanes 3, 6), GST-SET/TAF-Iβ (lanes 2, 5), GST-SET/TAF-Iβ (76–185) (lanes 1, 4) (2 μg each) bound on glutathione beads were 
incubated with 4 μg of purified H3 globular domain (lanes 1, 2, 3) or recombinant histone H3 (lanes 4, 5, 6). Bound proteins 
were eluted with 20 μl of reduced glutathione and samples were analysed by SDS-PAGE and Coomassie blue staining.BMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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bically in an antiparallel manner to form the dimer. The
earmuff domain is attached to the concave side of the
backbone helix and its lower part is highly mobile in
aqueous solution. Comparison of the crystal structure of
SET/TAF-Iβ with that of NAP-1 revealed that the two pro-
teins exhibit the highest similarity in the region of the ear-
muff domain. Inspection of the structure itself and
biochemical analysis of the wild-type protein and of 18
triple mutants led to important conclusions regarding the
histone and DNA binding properties of SET/TAF1β, which
provide insight into its histone chaperone function. More
specifically, Muto et al. [51] have shown that: (a) SET/
TAF1β has a histone chaperone activity specific to H3/H4,
(b) its acidic C-terminal stretch is not important for H3/
H4 binding and (c) the bottom part of the earmuff
domain, formed mainly by the β-structure, which is
exposed to the solvent, is more likely responsible for its
histone chaperone activity. No affinity measurements of
the tested interactions have been reported in that work.
Our approach, based on the design of deletion mutants
and functional domains of SET/TAF1β and on the quanti-
tative comparison of their affinities for histones, allowed
us to draw conclusions that extend and complement this
study [51] by shifting the focus towards affinity differ-
ences of isolated histones for the SET/TAF1β chaperone.
When the domains analysed in this work are mapped
onto the SET/TAF-Iβ sequence it becomes clear that the
central region of SET/TAF-Iβ, spanning residues 76–185 in
the earmuff domain, is crucial for histone binding. The
sequence of this particular region is extremely conserved
between human, mouse and Xenopus SET/TAF-Iβ and its
tertiary structure is very similar to the homologous region
in yeast NAP-1 (Fig. 4). It has been recently shown that the
amphipathic β-sheet formed in this region represents a
structural motif common to all histone chaperones with
known structures (NAP-1, nucleoplasmin, ASF1, CAF-1),
despite a wide variation in sequence, structural context
and overall architecture of the various chaperones
[12,13]. These observations suggest a strong evolutionary
conservation and underscore the relevance of this motif
for the common function of histone chaperones with
their differences accounting for distinct roles in chromatin
assembly. Moreover, our data provide concrete and quan-
titative evidence that removal of the acidic C-terminal tail
of SET/TAF-Iβ does not affect its affinity for histone H3. It
can be easily inferred from this observation that charge
neutralization between the basic histones and acidic chap-
erones is dispensable for their interaction, a conclusion
further supported by the complete absence of acidic
stretches in certain chaperones, such as ASF1 [52]. It can-
not be excluded, though, that post-translational modifica-
tions of the acidic stretch could have an effect on the
interaction between chaperones and their respective his-
tone substrates in vivo. Acidic stretches of NAP1 have been
shown to be highly polymorphic in a variety of tissues and
organisms due to various degrees of polyglutamylation
[12], a modification that could significantly affect the
charge and physicochemical properties of SET/TAF-Iβ in a
reversible manner and lead to further refinement of its
interaction with histones in vivo.
Very recently three different reports on the structure and
biochemistry of a new member of the histone chaperone
family, Vps75 from yeast [53], revealed a remarkable
structural similarity with SET/TAF-Iβ and, in agreement
with our observations, highlighted the importance of the
central cleft for histone binding [54-56]. Comparison of
the high resolution structures of Vps75 and SET/TAF-Iβ
clearly shows that the two proteins share, besides the over-
all topology, several other structural features, such as the
lack of the extended N-terminal tail and of the accessory
domain identified in NAP-1, which point to Vps75 as the
closest known structural homologue of SET/TAF-Iβ in
yeast (Fig. 4). Biochemical experiments with wild-type
and mutated Vsp75 show that its central cleft is important
for histone binding and for its interaction with the his-
tone acetyltransferase Rtt109. Significant functional simi-
larities with SET/TAF-Iβ include the predominantly
nuclear localization, the involvement in non-canonical
histone chaperone activities, the interaction with both
H2A/H2B and H3/H4, the irrelevance of the H3 tails for
this interaction and the lack of H2A/H2B dimer stripping
activity, in sharp contrast to NAP-1 which readily removes
H2A/H2B dimers from assembled nucleosomes [55].
There are, however, notable differences between the two
proteins, especially in the central cleft size and the intrin-
sic motion of this part resulting in altered charge density
and surface electrostatic potential, that have been corre-
lated with the unique function of Vps75 to interact with
Rtt109 for histone acetylation, but also with likely differ-
Mapping on the SET/TAF-Iβ structure of the central region  essential for H3 binding Figure 4
Mapping on the SET/TAF-Iβ structure of the central 
region essential for H3 binding. Views of the central 
region of SET/TAF-Iβ found to be essential for H3 binding in 
this work (blue), the homologous domain (named subdomain 
C) of yeast NAP-1 (green) and the homologous domain of 
yeast Vps75 (red). PDB codes used are 2E50 for human SET/
TAF-Iβ, 2AYU for yeast NAP-1 and 2ZD7 for yeast Vps75. 
The central β-sheet is a common structural motif found in all 
histone chaperones known todate. Molecular images were 
generated with PyMol [61].BMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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ent histone substrate specificities [54,56]. Evidence to this
direction is provided by our quantitative binding studies,
which indicate a clear preference of SET/TAF-Iβ for H3
over H2B binding, unlike Vps75 that has been shown to
preferentially interact with H2A/H2B [55]. In addition,
the histone chaperone activity of Vps75 has been found to
be intimately linked with stimulation of H3 acetylation
through the formation of the multifunctional Vps75-
Rtt109 complex that acetylates H3 and deposits H3/H4
onto DNA [54]. Affinity measurements for the interaction
of H3 with wild-type and Vps75 mutants previously
reported to be defective in histone binding and chaperone
activity of SET/TAF-Iβ [51] demonstrated that the region
of Vps75 responsible for Rtt109 activation is found in the
acidic cleft of Vps75, but is not the one involved in his-
tone binding [54]. This region corresponds to the stretch
209KDD211 of SET/TAF-Iβ which maps beyond the part we
identified as mainly responsible for the interaction with
H3. Overall, it appears that SET/TAF-Iβ, NAP-1 and
Vps75, although structurally very similar, are functionally
distinct members of the NAP family of histone chaper-
ones.
Conclusion
The quantitative study of the histone-binding properties of
SET/TAF-Iβ described here and its dissection in structural/
functional domains were based on a type of analysis, that has
not been extensively used in the chromatin field, but has
allowed us to draw several important conclusions regarding
its histone chaperone function. In short, our data showed
that SET/TAF-Iβ binds preferentially to histone H3, mainly
through its central region, while the dimerisation domain
and the acidic tail, both hallmarks of histone chaperones, are
not essential for the interaction. On the other hand, binding
of H3 to SET/TAF-Iβ, is mediated by its core region and does
not seem to depend on the presence or the modification sta-
tus of the H3 amino-terminal tail. Our findings regarding the
ability of distinct SET/TAF-Iβ domains to bind histones are in
good agreement (i) with inferences made by close inspection
of the tertiary structure, (ii) with the previously deduced 1:1
stoichiometry for the SET/H3 interaction, (iii) with recent
suggestions on the relevance of the central β-sheet motif for
the common function of histone chaperones [12] and (iv)
with the importance of affinity differences for histone chap-
erone activity [45,48]. Differences of SET/TAF-Iβ with other
histone chaperones, that could account for a distinct func-
tion, include the clear preference for H3 binding, the irrele-
vance of the H3 tails or their modification status for the
interaction and the inability to bind linker histone H1,
together with the recently reported lack of H2A/H2B dimer
stripping activity [49,50].
Methods
Expression and purification of recombinant proteins
SET/TAF-Iβ and fragments of SET/TAF-Iβ were subcloned
into pGEX vectors (Pharmacia) in frame with glutathione
S-transferase (GST). GST-proteins were expressed in BL21
cells and purified from lysates according to standard pro-
cedures [57]. To remove the GST moiety, GST-proteins
were immobilized on glutathione beads and digested
with the PreScission Protease (Amersham Pharmacia Bio-
tech), 2 units of enzyme/100 μg of bound GST-protien in
20 μl cleavage buffer (50 mM Tris-HCl, pH 7.0, 150 mM
NaCl, 1 mM EDTA, 1 mM DDT, 0.1% NP40) at 4°C for
12 h. Linker histone H1 and core histones H2A, H2B, H3
and H4 were obtained from Roche. A pET3a expression
vector carrying the cDNAs encoding H3 and histone H3
globular domain (aa 27–135) from Xenopus laevis was a
kind gift from K. Luger, University of Colorado (Califor-
nia, USA). Recombinant H3 and tailless H3 were
expressed in E. coli BL21 (DE3) cells and purified under
denaturing conditions using SP-sepharose chromatogra-
phy, as previously described [58]. After removal of urea
with extensive dialysis, the samples were lyophilized, dis-
solved in water and their concentration was adjusted to 1
mg/ml. The yeast H3 tail region (1–46) was expressed as
a fusion protein with a N-terminal GST tag from a pGET2T
expression vector kindly provided from M. Grunstein,
University of California and was purified according to
standard procedures [59]. Pull-down assays were per-
formed with fresh preparations of all histone constructs.
H3/H4 tetramer assembly
H3/H4 tetramer reconstitution was based on Luger et al,
1997 [1], with slight modifications. Native H4 was pur-
chased from Roche and dissolved in water at a concentra-
tion of 1 mg/ml. Recombinant H3 was prepared as
described above. The two proteins were mixed at equimo-
lar ratio and dialyzed against unfolding buffer (6 M Urea,
20 mM Tris-HCl pH 7.5, 5 mM β-mercaptoethanol) over-
night. Tetramer assembly was achieved using the salt-dial-
ysis method as follows: The histone mixture was dialyzed
against at least three changes of refolding buffer (2 M
NaCl, 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 5 mM β-mer-
captoethanol). Then, the concentration of NaCl was
adjusted by dialysis to 1 M, 0.5 M, 0.15 M for 5 h, except
the last dialysis step which was left overnight. Precipitated
material was removed by centrifugation and the reconsti-
tuted tetramer was tested directly in pull-down assays.
GST-pull down assays
Fusion proteins (approximately 2–3 μg each) were immo-
bilized on glutathione-Sepharose beads and incubated
with 4 μg of histones (H1, H2A, H2B, H3, H4) in TNMT
buffer (20 mM Tris-HCl, pH 7.5, 0.5 M NaCl, 2 mM
MgCl2 and 1% Triton X-100) in a total volume of 0.25 ml.
Reactions were carried out for 60 min at room tempera-
ture. The beads were harvested, washed three times and
resuspended in 25 μl of SDS sample buffer. For pull-down
assays using (H3/H4)2  tetramers, GST-SET/TAF-Iβ and
GST were immobilized on glutathione-agarose beads in
the washing buffer (20 mM Tris-HCl pH 7.5, 150 mMBMC Biochemistry 2009, 10:10 http://www.biomedcentral.com/1471-2091/10/10
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NaCl, 5% sucrose, 0.1% NP-40, 1 mM EDTA, 1 mM DTT,
1 mM PMSF). After washing the beads twice, H3/H4
tetramer was added and incubated for 1 h in the assay
buffer (20 mM Tris-HCl pH 7.5, 300 mM NaCl, 5%
sucrose, 0.1% NP-40, 1 mM EDTA, 1 mM DTT, 1 mM
PMSF, at room temperature. The beads were washed five
times with the assay buffer and once with the washing
buffer. Bound proteins were eluted with hot SDS-sample
buffer and samples were analysed on 13% SDS-polyacry-
lamide gels and detected by Coomassie Blue staining.
Fluorescence Spectroscopy Binding Assays
Binding of the various SET/TAF-Iβ constructs with his-
tones was followed by monitoring the intensity of the flu-
orescence emitted by the tryptophan residues of SET/TAF-
Iβ polypeptides upon addition of increasing amounts of
calf thymus histone H3 [46,47]. A Hitachi F-2500 fluores-
cence spectrophotometer, fitted with a thermostatically
controlled jacketed cell holder and interfaced with a
Neslab RTE-111 water-bath was used. Fluorescence emis-
sion spectra in the range 300–400 nm were recorded with
an excitation wavelength of 295 nm. SET/TAF-Iβ polypep-
tides at several initial concentrations ranging from 0.2 to
4 μM were titrated with increasing amounts of purified
calf thymus H3 stock solution in PBS buffer. All measure-
ments were performed at 25°C in a quartz cell with path
length of 1 cm (Hellma) under constant stirring. After
each ligand addition, the samples were left to equilibrate
for 10 min before the equilibrium fluorescence readings
were recorded. The dissociation constant (Kd) for the com-
plexes formed was estimated by non-linear regression
analysis (KaleidaGraph, Synergy Software) relating the
change in SET fluorescence intensity at 345 nm (corrected
for buffer contribution and for dilution) to the total
added histone concentration through Equation 1:
where F, F0, and Fmax are the fluorescence intensities meas-
ured at each titration point, at zero ligand concentration
and at saturation, respectively, and [L] is the concentra-
tion of free ligand calculated by solving the quadratic
equation
where [P]0 and [L]0 are the protein and total ligand con-
centrations added, respectively. Each titration was
repeated three times.
Circular Dichroism
Circular dichroism spectra in the Far UV range (180–260
nm) were recorded on a Jasco J-815 spectropolarimeter
interfaced with a Peltier element for temperature control.
The instrument was calibrated with a 0.1% aqueous solu-
tion of d-10-camphor sulfonic acid. Stock solutions of
SET/TAF-IB polypeptides were in 50 mM Tris-HCl pH 7.5,
150 mM NaCl, 0.5 mM DTT, 1 mM EDTA and their con-
centration ranged from 10 to 75 μM. Spectra were
recorded at 25°C, with 0.2 nm resolution, averaged over
five scans and were baseline corrected by subtraction of
the buffer spectrum at the same temperature. Quartz cells
with path lengths of 0.02 or 0.1 cm were used (Hellma).
The combined absorbance of cell, sample and solvent was
kept at < 1 over the measured range. Secondary structure
was estimated as described previously [60]. Molecular
images were generated with PyMol [61].
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